ICUI
ICU Medical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 2
MACD Death Cross
Revenue Beats Expectation
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About ICUI
Icu Medical, Inc.
A US-based medical device company that develops and manufactures infusion therapy and critical care products
Healthcare Equipment and Supplies
Invalid Date
03/31/1992
NASDAQ Stock Exchange
15000
12-31
Common stock
951 Calle Amanecer
, San Clemente
, California 92673
--
ICU Medical, Inc., was incorporated by its CEO in 1984 and made its initial public offering in 1992. The company is a leader in the development, production and sales of new medical devices for injection therapy, oncology and emergency care. The company's products improve patient recovery by helping to organize blood pressure infections, protecting healthcare workers and patients from exposure to infectious diseases or harmful drugs, and monitoring continuous cardiac output of emergency care patients. The company's complete product line includes custom injection systems, closed delivery systems for hazardous drugs, needle-free injection connectors, catheters and cardiac detection systems.
Company Financials
EPS
ICUI has released its 2024 Q4 earnings. EPS was reported at 2.11, versus the expected 1.48, beating expectations. The chart below visualizes how ICUI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ICUI has released its 2024 Q4 earnings report, with revenue of 629.80M, reflecting a YoY change of 7.14%, and net profit of -23.83M, showing a YoY change of -38.96%. The Sankey diagram below clearly presents ICUI’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
